New German study below [1].
"... squalene epoxidase (SQLE), an enzyme of the cholesterol biosynthesis pathway, is overexpressed in advanced PCa and its expression correlates with poor survival ..."
"Inhibition of SQLE with the FDA approved antifungal drug terbinafine ... efficiently blocked orthotopic tumour growth in mice."
"... terbinafine reduced levels of prostate specific antigen (PSA) in three out of four late-stage PCa patients."
Terbinafine [2] is an antifungal. "In the United States the price in 1999 was $547 for a 12-week course; this fell to $10 by 2015, after the patent had expired."
-Patrick
[1] pubmed.ncbi.nlm.nih.gov/344...
Nat Commun
. 2021 Aug 20;12(1):5066. doi: 10.1038/s41467-021-25325-9.
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer
C Kalogirou 1 2 , J Linxweiler 3 , P Schmucker 2 , M T Snaebjornsson 4 , W Schmitz 1 , S Wach 5 , M Krebs 2 , E Hartmann 6 , M Puhr 7 , A Müller 8 , M Spahn 9 , A K Seitz 2 , T Frank 2 , H Marouf 1 , G Büchel 1 10 , M Eckstein 11 , H Kübler 2 , M Eilers 1 , M Saar 3 , K Junker 3 , F Röhrig 1 , B Kneitz 2 , M T Rosenfeldt 6 , A Schulze 12 13
Affiliations collapse
Affiliations
1 Department of Biochemistry and Molecular Biology, Theodor-Boveri-Institute, Biocenter, Würzburg, Germany.
2 Department of Urology and Paediatric Urology, University Hospital Würzburg, Würzburg, Germany.
3 Department of Urology, Saarland University, Homburg/Saar, Germany.
4 German Cancer Research Center, Division of Tumor Metabolism and Microenvironment, Heidelberg, Germany.
5 Department of Urology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
6 Institute of Pathology, Julius Maximilians University and Comprehensive Cancer Center (CCC) Mainfranken, Würzburg, Germany.
7 Department of Urology, Medical University of Innsbruck, Innsbruck, Austria.
8 Clinic for Diagnostic and Interventional Radiology, Saarland University, Homburg/Saar, Germany.
9 Center for Urology, Hirslanden Private Hospital Group, Zurich, Switzerland.
10 Mildred Scheel Early Career Center, University Hospital Würzburg, Würzburg, Germany.
11 Institute of Pathology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany.
12 Department of Biochemistry and Molecular Biology, Theodor-Boveri-Institute, Biocenter, Würzburg, Germany. almut.schulze@dkfz-heidelberg.de.
13 German Cancer Research Center, Division of Tumor Metabolism and Microenvironment, Heidelberg, Germany. almut.schulze@dkfz-heidelberg.de.
PMID: 34417456 DOI: 10.1038/s41467-021-25325-9
Abstract
Prostate cancer (PCa) shows strong dependence on the androgen receptor (AR) pathway. Here, we show that squalene epoxidase (SQLE), an enzyme of the cholesterol biosynthesis pathway, is overexpressed in advanced PCa and its expression correlates with poor survival. SQLE expression is controlled by micro-RNA 205 (miR-205), which is significantly downregulated in advanced PCa. Restoration of miR-205 expression or competitive inhibition of SQLE led to inhibition of de novo cholesterol biosynthesis. Furthermore, SQLE was essential for proliferation of AR-positive PCa cell lines, including abiraterone or enzalutamide resistant derivatives, and blocked transactivation of the AR pathway. Inhibition of SQLE with the FDA approved antifungal drug terbinafine also efficiently blocked orthotopic tumour growth in mice. Finally, terbinafine reduced levels of prostate specific antigen (PSA) in three out of four late-stage PCa patients. These results highlight SQLE as a therapeutic target for the treatment of advanced PCa.